Net Cash Provided by (Used in) Financing Activities in USD of CORCEPT THERAPEUTICS INC from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Corcept Therapeutics Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2025.
  • Corcept Therapeutics Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$39.8M, a 7230% decline year-over-year.
  • Corcept Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$28.3M, a 80.9% increase from 2023.
  • Corcept Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$149M, a 760% decline from 2022.
  • Corcept Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$17.3M, a 94.3% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

CORCEPT THERAPEUTICS INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$39.8M -$39.3M -7230% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-05
Q1 2024 -$543K -$724K -400% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-05
Q1 2023 $181K +$687K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q1 2022 -$506K +$45.4M +98.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q1 2021 -$45.9M -$46.2M -22513% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $205K +$15.5M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 -$15.3M -$17.2M -895% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q1 2018 $1.92M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2012 $13.2M -$28.8M -68.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q1 2011 $41.9M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10

CORCEPT THERAPEUTICS INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$28.3M +$120M +80.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-26
2023 -$149M -$131M -760% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-26
2022 -$17.3M +$285M +94.3% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-26
2021 -$303M -$315M -2577% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $12.2M +$40.9M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$28.6M -$14.3M -99.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 -$14.3M -$6.38M -80.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 -$7.95M -$857K -12.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 -$7.1M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2013 -$970K -$90.5M -101% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-14
2012 $89.6M +$47.1M +111% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-14
2011 $42.5M +$19.5M +84.7% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-14
2010 $23M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.